CAMBRIDGE, MA – September 22, 2022 - Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its participation in upcoming healthcare investor conferences in September and October.
Conference Details:
| Event: | Jefferies Cell & Genetic Medicine Summit |
|---|
| Date/Time: | Thursday, September 29th at 8:30 a.m. ET |
|---|
| Location: | New York, NY |
|---|
| Format: | Corporate Presentation |
|---|
| Event: | Chardan 6th Annual Genetic Medicines Conference |
|---|
| Date/Time: | Monday, October 3rd at 9:30 a.m. ET and 11:30 a.m. ET |
|---|
| Location: | New York, NY |
|---|
| Format: | Panel and Corporate Presentation, respectively |
|---|
| Event: | BMO Biopharma Spotlight Series: Gene Editing & Therapeutics |
|---|
| Date/Time: | Thursday, October 6th at 12:00 p.m. ET |
|---|
| Location: | Virtual |
|---|
| Format: | Panel |
|---|
| Event: | Oppenheimer Private Company Showcase |
|---|
| Date/Time: | Tuesday, October 18th at 2:10 p.m. PT |
|---|
| Location: | Palo Alto, CA |
|---|
| Format: | Corporate Presentation |
|---|
A webcast of the Jefferies Cell & Genetic Medicine Summit presentation will be accessible through the News Section of the company’s website at www.arbor.bio, with a replay available for 90 days following the event.
